1. Home
  2. NWPX vs ESPR Comparison

NWPX vs ESPR Comparison

Compare NWPX & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NWPX

Northwest Pipe Company

HOLD

Current Price

$74.67

Market Cap

722.9M

Sector

Industrials

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.43

Market Cap

793.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NWPX
ESPR
Founded
1966
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
722.9M
793.7M
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
NWPX
ESPR
Price
$74.67
$3.43
Analyst Decision
Buy
Buy
Analyst Count
2
6
Target Price
$60.00
$6.67
AVG Volume (30 Days)
91.2K
4.4M
Earning Date
02-25-2026
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
24.50
N/A
EPS
3.66
N/A
Revenue
$519,991,000.00
$303,802,000.00
Revenue This Year
$8.18
$27.49
Revenue Next Year
$1.02
N/A
P/E Ratio
$20.26
N/A
Revenue Growth
7.64
2.83
52 Week Low
$36.97
$0.69
52 Week High
$77.43
$4.18

Technical Indicators

Market Signals
Indicator
NWPX
ESPR
Relative Strength Index (RSI) 63.92 49.78
Support Level $68.13 $3.16
Resistance Level $77.43 $3.52
Average True Range (ATR) 2.44 0.19
MACD 0.32 0.02
Stochastic Oscillator 63.53 53.12

Price Performance

Historical Comparison
NWPX
ESPR

About NWPX Northwest Pipe Company

NWPX Infrastructure Inc is a manufacturer of water-related infrastructure products. The Company is the manufacturer of engineered water transmission systems in North America and produces steel casing pipe, bar-wrapped concrete cylinder pipe, and pipeline system joints and fittings through its Engineered Steel Pressure Pipe segment. The Company provides solution-based products for a wide range of markets, including high-quality reinforced precast concrete products, lined precast sanitary sewer system components, water distribution and management equipment, including pump lift stations, wastewater pretreatment, and stormwater quality products through its Precast Infrastructure and Engineered Systems segment.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: